Category: Research
The content below was provided by Jocelyn Herstein, an assistant professor at UNMC and Director of International Partnerships and Programs with the National Emerging Special Pathogens Training and Education Center. She led a recently published study, collaborating with UNMC ID faculty Drs. Angela Hewlett and James Lawler. What prompted this study? Emerging infectious disease events require a […]
Apr 26, 2022
Publication Alert: Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia.
This content was provided by Darryl Sokpa, PharmD/MBA ’22 candidate at UNMC College of Pharmacy. He led a recently published study, collaborating UNMC ID faculty Drs. Sara Bares and Nada Fadul, and mentored by UNMC ID pharmacist faculty Dr. Joshua Havens.
Mar 15, 2022
Ongoing Debate on the Treatment of Staphylococcus aureus Bacteremia
Dr. Andre Kalil, our Director of Transplant Infectious Diseases, recently co-authored a reply to Geriak et al.: “Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.” Debate around the findings of this article was recently featured by Dr. Razan El Ramahi in the IDSA ID […]
Apr 13, 2020
In 2018, we experienced a particularly severe West Nile Virus season, with an unusually high amount of neuroinvasive disease. Last summer, our senior ID Fellow Dr. Lindsey Rearigh shared an informational blog post about the disease, and more recently, she and Dr. Sara Bares published a case report in the Journal of Neurovirology describing a […]
Mar 23, 2020
COVID-19 – What is UNMC ID doing?
Although it has not been officially declared a pandemic by the World Health Organization (WHO), as of this morning, there were 81, 191 confirmed cases of COVID-19 and 2,768 deaths worldwide. To date, 57 of these cases are within US borders, and there are increasing cases throughout the world. UNMC & Nebraska Medicine have had […]
Feb 26, 2020
Evaluating Next-Generation Melioidosis Diagnostics
In addition to being one of our ID physicians, Dr. James Lawler serves as the Director or International Programs and Innovation at the Global Center for Health Security, a center that will focus on training federal personnel to manage highly infectious diseases, and Director of Clinical and Biodefense Research at the National Strategic Research Institute. His interest in […]
Dec 23, 2019
Following up on pharmacist-led HIV pre-exposure prophylaxis
Earlier this year we featured a study by UNMC ID Drs. Sara Bares and Susan Swindells: “Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.” We’re excited to share an update on their work building inter-professional relationships to increase PrEP education and use in Nebraska that was recently published in Open Forum […]
Dec 6, 2019
Are you ever involved with prescribing antibiotics in the hospital? We want to hear from you!
The Nebraska Medicine Antimicrobial Stewardship Program (ASP) invites you to participate in a research survey entitled: Use of Oral Antibiotic Therapy (OAT) for Definitive Treatment of Uncomplicated Bloodstream Infections (uBSIs): Opportunities for Antimicrobial Stewardship. There are several studies describing successful use of oral antibiotics to treat bloodstream infections, but are clinicians actually using oral antibiotics […]
Nov 14, 2019
#IDWeek2019: An infectious air of inclusion, knowledge, and empowerment
This year, our ID division was well represented at IDWeek, with several residents and students attending (and presenting) for the first time. One of our third year Internal Medicine/Pediatrics residents interested in Infectious Diseases, Dr. Joe Wang, wrote about his experiences, published last week on Doximity. We are very proud of him and share his […]
Oct 21, 2019
Placing PICCs for Antibiotics – Potential Undue Risks May Outweight Benefits
PICC placement is common practice for intravenous (IV) antibiotic needs, however, we may be inadvertently placing certain patients at higher risks for complications. A recent study by Paje et al assessed the frequency of PICC placement among patients with CKD stage 3b or greater, a practice discordant with current guidelines. This prospective study included data […]
Jul 19, 2019
Recent Comments